Showing results (31-40 of 165) with videos related to
Sort By:
Pageof 17
European Journal of Cancer (Oxford, England : 1990)|January 1, 1996
Anti-oestrogen stimulation of ERBB2 ectodomain shedding from BT-474 human breast cancer cells with ERBB2 gene amplificationA M Wärri, J J Isola, P L HärkönenJournal of the National Cancer Institute|July 15, 1992
Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patientsJ Isola, T Visakorpi, K Holli, et al.The American Journal of Pathology|April 1, 1993
Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancerS M Siitonen, O P Kallioniemi, J J IsolaThe Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|February 19, 2000
Direct eye visualization of Cy5 fluorescence for immunocytochemistry and in situ hybridizationG L Ferri, J Isola, P Berger, et al.Neuroscience Letters|May 18, 1990
Simultaneous localization of calcitonin gene-related peptide and neurotensin in rat central amygdaloid nucleusJ Honkaniemi, M Pelto-Huikko, J Isola, et al.Hematological Oncology|September 1, 1992
Accumulation of p53 protein correlates with tumour proliferative activity in EBV positive Burkitt's lymphomaT Lehtinen, J Isola, R Aine, et al.Journal of Clinical Pathology|March 1, 2005
Ultrarapid Ki-67 immunostaining in frozen section interpretation of gliomasJ Haapasalo, A Mennander, P Helen, et al.The American Journal of Pathology|January 7, 2000
Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancerT A Järvinen, M Pelto-Huikko, K Holli, et al.Cancer Research|February 28, 2001
Chromosomal rearrangements and oncogene amplification precede aneuploidization in the genetic evolution of breast cancerK Rennstam, B Baldetorp, S Kytölä, et al.British Journal of Cancer|July 2, 1998
Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancerT A Järvinen, K Holli, T Kuukasjärvi, et al.Pageof 17